Form 8-K - Current report:
SEC Accession No. 0001504776-25-000024
Filing Date
2025-08-07
Accepted
2025-08-07 06:56:28
Documents
13
Period of Report
2025-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K wrby-20250804.htm   iXBRL 8-K 30505
2 EX-99.1 warbyparkerincearningsrele.htm EX-99.1 278787
  Complete submission text file 0001504776-25-000024.txt   456337

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT wrby-20250804.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT wrby-20250804_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT wrby-20250804_pre.xml EX-101.PRE 13581
15 EXTRACTED XBRL INSTANCE DOCUMENT wrby-20250804_htm.xml XML 2814
Mailing Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013
Business Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013 (646) 847-7215
Warby Parker Inc. (Filer) CIK: 0001504776 (see all company filings)

EIN.: 800423634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)